Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RP11-722G7.1 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
mRNA | ZIK1 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
mRNA | FBXO25 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
mRNA | SEZ6 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
mRNA | CDKN2C | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
mRNA | C14orf132 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-09 |
mRNA | ZNF250 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
mRNA | SRRM3 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
mRNA | GPRIN1 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
mRNA | RP11-15H20.8 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |